Physician profile
Eric E Berg
NPI 1265619696
$2,149.50
in general payments reported to CMS, 2019-2025
10 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Pediatric Otolaryngology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.60 · 2020: $27.56 · 2024: $1,932 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,061 · Food and Beverage: $1,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,060.74 |
| Food and Beverage | $1,034.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,760.80 | 2024-2025 | Coblation, Tula |
| Regeneron Healthcare Solutions, INC. | $145.21 | 2024 | Dupixent |
| Stryker Corporation | $54.37 | 2024 | Na |
| Becton, Dickinson and Company | $34.42 | 2025 | Arista |
| Preceptis Medical, INC. | $33.76 | 2024 | Hummingbird Tympanostomy Tube System |
| Karl Storz Endoscopy-America | $27.56 | 2020 | |
| Medtronic USA, INC. | $26.60 | 2019 | |
| Genzyme Corporation | $25.12 | 2025 | |
| Acera Surgical, INC. | $24.87 | 2025 | Restrata Wound Matrix |
| Cumberland Pharmaceuticals, INC. | $16.79 | 2024 | Caldolor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Berg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.